Source link : https://www.newshealth.biz/health-news/rytelo-recommended-in-europe-for-myelodysplastic-syndromes/
The European Medicines Agency (EMA) has given a positive recommendation for Rytelo (imetelstat) for the treatment of adult patients with transfusion-dependent anemia due to very low-, low-, or intermediate-risk myelodysplastic syndromes. Myelodysplastic syndromes are a group of cancers in which blood cells in the bone marrow do not mature, build up, and crowd out healthy […]
Author : News Health
Publish date : 2024-12-13 17:46:47
Copyright for syndicated content belongs to the linked Source.